Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase
Gönül Yapar, Hatice Esra Duran, Nebih Lolak, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105473-105473
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors
Aida Buza, Cüneyt Türkeş, Mustafa Arslan, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124232-124232
Closed Access | Times Cited: 62
Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6359-6377
Closed Access | Times Cited: 46
Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107221-107221
Closed Access | Times Cited: 39
Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors
Nebih Lolak, Süleyman Akocak, Mustafa Durgun, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1735-1749
Closed Access | Times Cited: 47
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors
Yeliz Demir, Feyzi Sinan Tokalı, Erbay Kalay, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1713-1733
Closed Access | Times Cited: 46
Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif
Yeliz Demir, Cüneyt Türkeş, M. Serdar Çavuş, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 36
Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors
Feyzi Sinan Tokalı, Yeliz Demir, Cüneyt Türkeş, et al.
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 275-295
Closed Access | Times Cited: 34
A novel series of thiosemicarbazone hybrid scaffolds: Design, synthesis, DFT studies, metabolic enzyme inhibition properties, and molecular docking calculations
Hasan Yakan, Halit Muğlu, Cüneyt Türkeş, et al.
Journal of Molecular Structure (2023) Vol. 1280, pp. 135077-135077
Closed Access | Times Cited: 27
Exploration of Some Bis‐Sulfide and Bis‐Sulfone Derivatives as Non‐Classical Aldose Reductase İnhibitors
Cüneyt Türkeş, Yeliz Demir, Abdullah Biçer, et al.
ChemistrySelect (2023) Vol. 8, Iss. 5
Closed Access | Times Cited: 19
Investigations into the anti-inflammatory and anti-diabetic activity of newly synthesized derivatives of 4AP2BOB utilizing DFT, molecular docking and spectroscopic characterization
M. Selvakumaran, Predhanekar Mohamed Imran, Attar Kubaib, et al.
Journal of Molecular Liquids (2024) Vol. 396, pp. 123983-123983
Closed Access | Times Cited: 8
New bis hydrazone: Synthesis, X-ray crystal structure, DFT computations, conformational study and in silico study of the inhibition activity of SARS-CoV-2
Abdelkader Tabbiche, Abdelaziz Bouchama, Nadjib Chafai, et al.
Journal of Molecular Structure (2022) Vol. 1261, pp. 132865-132865
Open Access | Times Cited: 31
N‐substituted phthalazine sulfonamide derivatives as non‐classical aldose reductase inhibitors
Cüneyt Türkeş, Mustafa Arslan, Yeliz Demir, et al.
Journal of Molecular Recognition (2022) Vol. 35, Iss. 12
Closed Access | Times Cited: 30
Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun
ACS Omega (2024) Vol. 9, Iss. 18, pp. 20338-20349
Open Access | Times Cited: 5
Esculetin improves inflammation of the kidney via gene expression against doxorubicin-induced nephrotoxicity in rats: In vivo and in silico studies
Medine Sibel Karağaç, Esra Nur Yeşilkent, Duygu Kizir, et al.
Food Bioscience (2024), pp. 105159-105159
Closed Access | Times Cited: 4
Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors
Işıl Nihan Korkmaz, Cüneyt Türkeş, Yeliz Demir, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 11
Closed Access | Times Cited: 25
In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**
Cüneyt Türkeş, Yeliz Demir, Şükrü Beydemir
ChemistrySelect (2022) Vol. 7, Iss. 48
Open Access | Times Cited: 23
Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies
Işıl Nihan Korkmaz, Cüneyt Türkeş, Yeliz Demir, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 21
A new series of hydrazones as small‐molecule aldose reductase inhibitors
Mehlika Dilek Altıntop, Yeliz Demir, Cüneyt Türkeş, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 4
Closed Access | Times Cited: 13
Isolation of phenolic compounds from eco‐friendly white bee propolis: Antioxidant, wound‐healing, and anti‐Alzheimer effects
Adem Necip, İbrahim Demirtaş, Seçil Erden Tayhan, et al.
Food Science & Nutrition (2023) Vol. 12, Iss. 3, pp. 1928-1939
Open Access | Times Cited: 11
Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complications
Cüneyt Türkeş
Archives of Biochemistry and Biophysics (2024), pp. 110161-110161
Closed Access | Times Cited: 3
Protective effect of bromelain on some metabolic enzyme activities in tyloxapol‐induced hyperlipidemic rats
Ayşe Nurseli Sulumer, Esra Palabıyık, Bahri Avcı, et al.
Biotechnology and Applied Biochemistry (2023) Vol. 71, Iss. 1, pp. 17-27
Open Access | Times Cited: 10
The synthesis, biological evaluation and in silico studies of asymmetric 3,5-diaryl-rhodanines as novel inhibitors of human carbonic anhydrase isoenzymes
Kemal Yararli, Ebru Bilen Ozer, Sinan Bayındır, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134783-134783
Closed Access | Times Cited: 16
Selectivity Challenges for Aldose Reductase Inhibitors: A Review on Comparative SAR and Interaction Studies
Preety Kumari, Rupali Kohal, Bhavana, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139207-139207
Closed Access | Times Cited: 2
Exploring the Inhibitory Effects of Quinolone Medications on Carbonic Anhydrase Enzyme Activity: In Vitro and In Silico Investigation
Yeliz Demir
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 2
Design, Synthesis, and Bioactivity of Aldisine Derivatives Containing Oxime and Hydrazine Moieties Based on Hydrogen Bonds
Wentao Xu, Rongxin Yang, Lixia Liu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 29, pp. 11016-11025
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top